Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Short communication: neutralizing antibodies in HIV-1-infected Brazilian individuals.

Almeida DV, Morgado MG, Côrtes FH, Guimarães ML, Mendonça-Lima L, Pilotto JH, Grinsztejn B, Veloso VG, Bongertz V.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):488-92. doi: 10.1089/AID.2012.0052. Epub 2012 Dec 18.

2.

International network for comparison of HIV neutralization assays: the NeutNet report II.

Heyndrickx L, Heath A, Sheik-Khalil E, Alcami J, Bongertz V, Jansson M, Malnati M, Montefiori D, Moog C, Morris L, Osmanov S, Polonis V, Ramaswamy M, Sattentau Q, Tolazzi M, Schuitemaker H, Willems B, Wrin T, Fenyö EM, Scarlatti G.

PLoS One. 2012;7(5):e36438. doi: 10.1371/journal.pone.0036438. Epub 2012 May 9.

3.

Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.

Bello G, Velasco-de-Castro CA, Bongertz V, Rodrigues CA, Giacoia-Gripp CB, Pilotto JH, Grinsztejn B, Veloso VG, Morgado MG.

J Med Virol. 2009 Oct;81(10):1681-90. doi: 10.1002/jmv.21565.

PMID:
19697415
4.

International network for comparison of HIV neutralization assays: the NeutNet report.

Fenyö EM, Heath A, Dispinseri S, Holmes H, Lusso P, Zolla-Pazner S, Donners H, Heyndrickx L, Alcami J, Bongertz V, Jassoy C, Malnati M, Montefiori D, Moog C, Morris L, Osmanov S, Polonis V, Sattentau Q, Schuitemaker H, Sutthent R, Wrin T, Scarlatti G.

PLoS One. 2009;4(2):e4505. doi: 10.1371/journal.pone.0004505. Epub 2009 Feb 20.

5.

Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatment.

Bongertz V, Ouverney EP, Fernandez SC, Grinsztejn B, Veloso V, Couto-Fernandez JC, Pilotto JH, Morgado MG.

Mem Inst Oswaldo Cruz. 2007 Nov;102(7):817-25. Epub 2007 Dec 11.

6.

Design, synthesis and pharmacological evaluation of HIV-1 reverse transcriptase inhibition of new indolin-2-ones.

Boechat N, Kover WB, Bongertz V, Bastos MM, Romeiro NC, Azevedo ML, Wollinger W.

Med Chem. 2007 Nov;3(6):533-42.

PMID:
18045202
7.

HIV-1 binding and neutralizing antibodies of injecting drug users.

Ouverney EP, Teixeira SL, Silva-de-Jesus C, Hacker MA, Morgado MG, Bastos FI, Bongertz V.

Braz J Med Biol Res. 2005 Sep;38(9):1313-20. Epub 2005 Aug 26.

8.

Extra controls will waste yet more research time.

Bongertz V.

Nature. 2005 Aug 25;436(7054):1088. No abstract available.

PMID:
16121154
9.

Is human immunodeficiency virus/acquired immunodeficiency syndrome decreasing among Brazilian injection drug users? Recent findings and how to interpret them.

Bastos FI, Bongertz V, Teixeira SL, Morgado MG, Hacker MA.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):91-6. Epub 2005 Apr 12. Review.

10.

Human immunodeficiency virus type 1 neutralization by plasma from B or F genotype infected individuals.

Bongertz V, Teixeira SL, Grinztejn B, Pilotto JH, Veloso VG, Morgado MG, Bastos FI, Ouverney EP.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):85-9. Epub 2005 Apr 12.

11.

Report of the Fifth Brazilian Symposium on HIV/AIDS Research. Rio de Janeiro, RJ, Brazil. November 23-26, 2003.

Bongertz V, Bou-Habib DC, Castello-Branco LR, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):67-71. Epub 2005 Apr 12. No abstract available.

12.

The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil.

Hacker MA, Friedman SR, Telles PR, Teixeira SL, Bongertz V, Morgado MG, Bastos FI.

Subst Use Misuse. 2005;40(1):99-123.

PMID:
15702651
13.

HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity.

Teixeira SL, Bastos FI, Telles PR, Hacker MA, Brigido LF, de F Oliveira CA, Bongertz V, Morgado MG.

J Clin Virol. 2004 Nov;31(3):221-6.

PMID:
15465416
14.

Anti-human immunodeficiency virus-1 antibody titers in injection drug users compared to sexually infected individuals.

Bongertz V, Ouverney EP, Teixeira SL, Silva-de-Jesus C, Hacker MA, Morgado MG, Bastos FI.

Mem Inst Oswaldo Cruz. 2003 Mar;98(2):209-12. Epub 2003 May 15.

15.

Neutralization titres and vertical HIV-1 transmission.

Bongertz V, Costa CI, Veloso VG, Grinsztejn B, Filho EC, Calvet G, Pilotto JH.

Scand J Immunol. 2002 Dec;56(6):642-4.

16.

Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II.

Guimarães ML, Bastos FI, Telles PR, Galvão-Castro B, Diaz RS, Bongertz V, Morgado MG.

J Clin Virol. 2001 May;21(2):143-51.

PMID:
11378495
17.

Vertical human immunodeficiency virus type 1--HIV-1--transmission--a review.

Bongertz V.

Mem Inst Oswaldo Cruz. 2001 Jan;96(1):1-14. Review.

18.

Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.

Bongertz V, Costa CI, Veloso VG, Grinsztejn B, João Filho EC, Calvet G, Pilotto JH, Guimarães ML, Morgado MG.

Scand J Immunol. 2001 Mar;53(3):302-9.

19.

HIV-1 subtyping in Salvador, Bahia, Brazil: a city with African sociodemographic characteristics.

Couto-Fernandez JC, Morgado MG, Bongertz V, Tanuri A, Andrade T, Brites C, Galvão-Castro B.

J Acquir Immune Defic Syndr. 1999 Nov 1;22(3):288-93.

PMID:
10770350
20.

HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization.

Bongertz V, Bou-Habib DC, Brígido LF, Caseiro M, Chequer PJ, Couto-Fernandez JC, Ferreira PC, Galvão-Castro B, Greco D, Guimarães ML, Linhares de Carvalho MI, Morgado MG, Oliveira CA, Osmanov S, Ramos CA, Rossini M, Sabino E, Tanuri A, Ueda M.

J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):184-93.

PMID:
10737434
21.

Anti-HIV-1 seroreactivity and HIV transmission route[R1]. The HEC/FIOCRUZ AIDS Clinical Research Group.

Bongertz V, Guimarães ML, Soares-da-Costa MF, Veloso VG, Bastos FI, Szwarcwald CL, Derrico M, Telles PR, Pilloto JH, João Filho EC, Morgado MG.

J Clin Virol. 1999 Jan;12(1):27-36.

PMID:
10073411
22.

Report of the 2nd Brazilian Symposium on Basic Research in HIV/AIDS. Angra dos Reis, RJ, Brazil. September 7-11, 1997.

Bongertz V, Morgado MG, Castello-Branco LR, Galvão-Castro.

Mem Inst Oswaldo Cruz. 1998 May-Jun;93(3):367-71. No abstract available.

23.

Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil. Evandro Chagas Hospital AIDS Clinical Research Group.

Morgado MG, Guimarães ML, Gripp CB, Costa CI, Neves I Jr, Veloso VG, Linhares-Carvalho MI, Castello-Branco LR, Bastos FI, Kuiken C, Castilho EA, Galvão-Castro B, Bongertz V.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):488-94.

PMID:
9715846
24.

HIV specific humoral immune response in Rio de Janeiro, Brazil. The HEC/Fiocruz AIDS Clinical Research Group.

Bongertz V, Costa CI, Guimarães ML, Soares-da-Costa MF, Grinsztejn B, Bastos FI, Pilotto JH, João Filho EC, Loureiro R, Chequer P, Telles PR, Galvão-Castro B, Morgado MG.

Mem Inst Oswaldo Cruz. 1998 May-Jun;93(3):391-8.

25.

Molecular epidemiology of HIV in Brazil: polymorphism of the antigenically distinct HIV-1 B subtype strains. The Hospital Evandro Chagas AIDS Clinical Research Group.

Morgado MG, Guimarães ML, Neves Júnior I, dos Santos VG, Linhares-de-Carvalho MI, Castello-Branco LR, Bastos FI, Castilho EA, Galvão-Castro B, Bongertz V.

Mem Inst Oswaldo Cruz. 1998 May-Jun;93(3):383-6. No abstract available.

26.

Neutralization susceptibility of B subtype variant B" primary HIV-1 isolates. The HEC/FIOCRUZ AIDS Clinical Research Group.

Bongertz V, Costa CI, Guimarães ML, Grinsztejn B, João Filho EC, Galvão-Castro B, Morgado MG.

Scand J Immunol. 1998 Jun;47(6):603-8.

27.
28.

HIV-1 isolation from plasma specimens. HEC/FIOCRUZ AIDS Clinical Research Group.

Costa CI, Morgado MG, Santos VG, Bongertz V.

Mem Inst Oswaldo Cruz. 1996 Nov-Dec;91(6):745-6. No abstract available.

29.

Immunoreactivity of Brazilian HIV isolates with different V3 motifs.

Hendry RM, Hanson CV, Bongertz V, Morgado M, Duarte A, Casseb J, Brigido L, Sabino E, Diaz R, Galvão-Castro B.

Mem Inst Oswaldo Cruz. 1996 May-Jun;91(3):347-8. No abstract available.

30.

Neutralization of primary HIV-1 isolated from individuals residing in Rio de Janeiro. HEC/FIOCRUZ AIDS Clinical Research Group.

Bongertz V, Costa CI, Grinsztejn B, Pilotto JH, João Filho EC, Morgado MG.

Mem Inst Oswaldo Cruz. 1996 May-Jun;91(3):343-5. No abstract available.

31.

Polymorphism of the predictive antigenic sites on the V3 loop of Brazilian HIV-1 subtype B strains. HEC/FIOCRUZ AIDS Clinical Research Group.

Morgado MG, Guimarães ML, Gripp CB, Neves Júnior I, Costa CI, dos Santos VG, Linhares-de-Carvalho MI, Galvão-Castro B, Bongertz V.

Mem Inst Oswaldo Cruz. 1996 May-Jun;91(3):339-42. No abstract available.

32.

A nationwide effort to sistematically monitor HIV-1 diversity in Brazil: preliminary results. Brazilian Network for the HIV-1 Isolation and Characterization.

Galvão-Castro B, Couto-Fernandez JC, Mello MA, Linhares-de-Carvalho MI, Castello-Branco LR, Bongertz V, Ferreira PC, Morgado M, Sabino E, Tanuri A.

Mem Inst Oswaldo Cruz. 1996 May-Jun;91(3):335-8. No abstract available.

33.

Report of the First Brazilian Symposium on Basic Research in HIV/AIDS.

Galvão-Castro B, Branco LR, Morgado MG, Bongertz V.

Mem Inst Oswaldo Cruz. 1996 May-Jun;91(3):329-34. No abstract available.

34.

Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil.

Sabino EC, Shpaer EG, Morgado MG, Korber BT, Diaz RS, Bongertz V, Cavalcante S, Galvão-Castro B, Mullins JI, Mayer A.

J Virol. 1994 Oct;68(10):6340-6.

36.

Analysis of antibody specificity against the third variable region of the envelope glycoprotein gp120 of HIV-1 in plasma from HIV-1-positive individuals residing in Brazil.

Bongertz V, Jansson M, Flodby P, Morgado MG, Galvão-Castro B, Wigzell H.

Braz J Med Biol Res. 1994 May;27(5):1225-36.

PMID:
8000344
37.

V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F.

Morgado MG, Sabino EC, Shpaer EG, Bongertz V, Brigido L, Guimaraes MD, Castilho EA, Galvão-Castro B, Mullins JI, Hendry RM, et al.

AIDS Res Hum Retroviruses. 1994 May;10(5):569-76.

PMID:
7522493
38.

Correlation between anti-V3 peptide and neutralizing antibodies in plasma from HIV-1 infected individuals resident in Brazil.

Bongertz V, Morgado MG, Galvão-Castro B, Wigzell H, Hendry RM.

Mem Inst Oswaldo Cruz. 1994 Jan-Mar;89(1):113-4.

39.

Production of monoclonal antibodies for the identification of a strain of Trypanosoma cruzi.

Bongertz V, Pontes de Carvalho LC.

Am J Trop Med Hyg. 1992 Apr;46(4):435-9.

PMID:
1575290
40.

Production of human monoclonal antibodies against HIV-1 peptides.

Bongertz V, Wigzell H, Rossi P.

Braz J Med Biol Res. 1991;24(8):815-8.

PMID:
1797270
41.

Synergistic signal of an anti-hamster T cell monoclonal antibody on antigen-induced T cell proliferation.

Rodrigues-Júnior V, Fortes FM, Bongertz V, Campos-Neto A.

Braz J Med Biol Res. 1990;23(12):1279-88.

PMID:
2136562
42.

Control of mycoplasma contamination in hybridoma technology.

Bongertz V, Thomaz N.

Mem Inst Oswaldo Cruz. 1988 Apr-Jun;83(2):265-6. No abstract available.

43.

[Elution of proteins from polyacrylamide gel: description of a simple and economic method].

Bongertz V.

Rev Inst Med Trop Sao Paulo. 1989 Jan-Feb;31(1):44-7. Portuguese.

PMID:
2814203
44.

Production of a monoclonal anti-hamster thymocyte antibody with mitogenic properties.

Bongertz V, Chequer-Bou-Habib D, Galvão-Castro B, Campos-Neto A.

Hybridoma. 1988 Feb;7(1):33-9.

PMID:
2453445
45.

Isolation and antigenic characterization of human immunodeficiency virus (HIV) in Brazil.

Galvão-Castro B, Ivo-Dos-Santos J, Couto-Fernandez JC, Bongertz V, Chequer-Bou-Habib D, Sion FS, Barth OM, Pereira H, Pereira MS.

Mem Inst Oswaldo Cruz. 1987 Oct-Dec;82(4):453-6.

46.

Trypanosoma cruzi: antigenic analysis of cloned stocks.

Bongertz V, Dvorak JA.

Am J Trop Med Hyg. 1983 Jul;32(4):716-22.

PMID:
6349399
47.

Trypanosoma cruzi: circulating antigens.

Bongertz V, Hungerer KD, Galvão-Castro B.

Mem Inst Oswaldo Cruz. 1981 Jan-Mar;76(1):71-82. No abstract available.

48.

Trypanosoma cruzi: isolation and characterization of a protease.

Bongertz V, Hungerer KD.

Exp Parasitol. 1978 Jun;45(1):8-18. No abstract available.

PMID:
352716

Supplemental Content

Loading ...
Support Center